期刊文献+

依维莫司洗脱支架对治疗稳定型心绞痛的临床疗效研究 被引量:1

下载PDF
导出
摘要 心绞痛主要原因是冠状动脉区域供血出现问题,导致心肌短暂性缺血或缺氧而引起胸部不适或者胸痛、胸闷、咽部紧缩等症状。目前临床上治疗心绞痛较为常用的手段为药物治疗或者介入的方式治疗,介入治疗通常利用药物洗脱支架植入减少冠状动脉狭窄或者阻塞的发生^([1]),但单纯性金属支架具有较高的冠状动脉狭窄再发生率,所以药物洗脱支架近几年来在临床上应用率比较高,已达到90%左右^([2])。本研究主要是利用依维莫司洗脱支架对于治疗稳定型心绞痛的临床有效性和安全性进行分析。报告如下。
出处 《山西医药杂志》 CAS 2021年第6期994-996,共3页 Shanxi Medical Journal
  • 相关文献

参考文献4

二级参考文献39

  • 1STONE G W,ELLIS S G,COX D A,et al.A polymer based,paeclitaxel eluting stent in patients with coronary artery disease[J].N Engl J Med,2004,350(3):221-231.
  • 2MOSES L W,LEON M B,POPMA J J,et al.Sirolimus eluting native coronary artery[J].N EngI J Med,2003,349(14):1315-1323.
  • 3MEREDITH I,ORMISTON J,WHITBOURN R,et al.First-in-human study of the endeavor zotarolimus-eluting phosphory 1-choline-encapsulated stent system in denovo native coronary artery lesions:Endeavor I trial[J].Euro Intervention,2005,1(5):157-164.
  • 4FAJADET J,WIJNS W,LAARMAN G J,et al.Randomized,double-blind,multicenter study of the Endeavor zotarolimus-eluting phosphory 1-choline-encapsulated stent for treatment of native coronary artery lesions.Clinical and angiographic results of the ENDEAVOR Ⅱ Trial[J].Minerva Cardioangiol,2007,55(1):1-18.
  • 5Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC),Steg PG,James SK,et al.ESC Guidelines for the management of acute myocardial infarction in patients presenting with STsegment elevation[J].Eur Heart J,2012,33(20):2569-619.
  • 6Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization[J].N Engl J Med,2002,346(23):1773-80.
  • 7Kedhi E,Joesoef KS,McFadden E,et al.Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE):a randomised trial[J].Lancet,2010,375(9710):201-9.
  • 8Serruys PW,Ruygrok P,Neuzner J,et al.A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial[J].EuroIntervention,2006,2(3):286-94.
  • 9Park DW,Kim YH,Song HG,et al.Comparison of everolimus-and sirolimus-eluting stents in patients with long coronary artery lesions:a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial[J].JACC Cardiovasc Interv,2011,4(10):1096-103.
  • 10Park KW,Chae IH,Lim DS,et al.Everolimus-eluting versus sirolimuseluting stents in patients undergoing percutaneous coronary intervention:the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial[J].J Am Coll Cardiol,2011,58(18):1844-54.

共引文献18

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部